173 related articles for article (PubMed ID: 7752257)
1. Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7.
Dubinett SM; Huang M; Dhanani S; Economou JS; Wang J; Lee P; Sharma S; Dougherty GJ; McBride WH
J Natl Cancer Inst; 1995 Apr; 87(8):593-7. PubMed ID: 7752257
[TBL] [Abstract][Full Text] [Related]
2. Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity.
McBride WH; Thacker JD; Comora S; Economou JS; Kelley D; Hogge D; Dubinett SM; Dougherty GJ
Cancer Res; 1992 Jul; 52(14):3931-7. PubMed ID: 1617669
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of macrophage transforming growth factor-beta messenger RNA expression by IL-7.
Dubinett SM; Huang M; Dhanani S; Wang J; Beroiza T
J Immunol; 1993 Dec; 151(12):6670-80. PubMed ID: 8258684
[TBL] [Abstract][Full Text] [Related]
4. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
Alleva DG; Walker TM; Elgert KD
J Leukoc Biol; 1995 Jun; 57(6):919-28. PubMed ID: 7790775
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity.
Sharma S; Wang J; Huang M; Paul RW; Lee P; McBride WH; Economou JS; Roth MD; Kiertscher SM; Dubinett SM
Cancer Gene Ther; 1996; 3(5):302-13. PubMed ID: 8894249
[TBL] [Abstract][Full Text] [Related]
8. Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo.
Chiang CS; Syljuäsen RG; Hong JH; Wallis A; Dougherty GJ; McBride WH
Cancer Res; 1997 Sep; 57(18):3899-903. PubMed ID: 9307268
[TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
[TBL] [Abstract][Full Text] [Related]
10. Aberrant TGF-beta production and regulation in metastatic malignancy.
Schwarz LC; Wright JA; Gingras MC; Kondaiah P; Danielpour D; Pimentel M; Sporn MB; Greenberg AH
Growth Factors; 1990; 3(2):115-27. PubMed ID: 2169772
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated interferon-gamma transfer inhibits growth of transplanted HTLV-1 Tax tumors in mice.
Xu X; Dai Y; Heidenreich O; Nerenberg MI
Hum Gene Ther; 1996 Mar; 7(4):471-7. PubMed ID: 8800741
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of cytokine gene expression during the in vitro CTL induction against a murine nonimmunogenic tumor.
Murata S; Eguchi Y; Mekata E; Tani T; Kodama M
Anticancer Res; 2000; 20(1A):363-72. PubMed ID: 10769681
[TBL] [Abstract][Full Text] [Related]
14. Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.
Park JA; Wang E; Kurt RA; Schluter SF; Hersh EM; Akporiaye ET
Cancer Gene Ther; 1997; 4(1):42-50. PubMed ID: 9012450
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
[TBL] [Abstract][Full Text] [Related]
16. Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-alpha and transforming growth factor-beta mRNA production.
Romieu R; Lacabanne V; Kayibanda M; Antoine B; Bennoun M; Chouaib S; Guillet JG; Viguier M
Int Immunol; 1997 Oct; 9(10):1405-13. PubMed ID: 9352345
[TBL] [Abstract][Full Text] [Related]
17. Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors.
Piccirillo CA; Prud'homme GJ
Hum Gene Ther; 1999 Aug; 10(12):1915-22. PubMed ID: 10466625
[TBL] [Abstract][Full Text] [Related]
18. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha.
Phan SH; Gharaee-Kermani M; McGarry B; Kunkel SL; Wolber FW
J Immunol; 1992 Jul; 149(1):103-6. PubMed ID: 1376744
[TBL] [Abstract][Full Text] [Related]
19. Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma model.
Dorigo O; Shawler DL; Royston I; Sobol RE; Berek JS; Fakhrai H
Gynecol Oncol; 1998 Nov; 71(2):204-10. PubMed ID: 9826461
[TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of TGF-bêta1, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma.
Toutirais O; Chartier P; Dubois D; Bouet F; Lévêque J; Catros-Quemener V; Genetet N
Eur Cytokine Netw; 2003; 14(4):246-55. PubMed ID: 14715418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
